Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) EBT (2018 - 2025)

AVITA Medical (RCEL) has disclosed EBT for 7 consecutive years, with -$11.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 123.18% year-over-year to -$11.6 million, compared with a TTM value of -$48.6 million through Dec 2025, down 373561.54%, and an annual FY2025 reading of -$48.6 million, down 373561.54% over the prior year.
  • EBT was -$11.6 million for Q4 2025 at AVITA Medical, up from -$13.2 million in the prior quarter.
  • Across five years, EBT topped out at $50.2 million in Q4 2024 and bottomed at -$18.6 million in Q1 2024.
  • Average EBT over 4 years is -$2.0 million, with a median of -$9.7 million recorded in 2022.
  • Peak annual rise in EBT hit 35.44% in 2025, while the deepest fall reached 123.18% in 2025.
  • Year by year, EBT stood at $29.3 million in 2022, then increased by 28.67% to $37.6 million in 2023, then skyrocketed by 33.4% to $50.2 million in 2024, then tumbled by 123.18% to -$11.6 million in 2025.
  • Business Quant data shows EBT for RCEL at -$11.6 million in Q4 2025, -$13.2 million in Q3 2025, and -$9.9 million in Q2 2025.